SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 2172401

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 2172401

Neurodiagnostic And Monitoring Devices Market In US 2026-2030

PUBLISHED:
PAGES: 222 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

The neurodiagnostic and monitoring devices market in US is forecasted to grow by USD 898.9 mn during 2025-2030, accelerating at a CAGR of 6.1% during the forecast period. The report on the neurodiagnostic and monitoring devices market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating incidence of acute neurological conditions and rapid bedside adoption, integration of AI and automated clinical workflow solutions, surging adoption of continuous intraoperative monitoring in complex surgeries.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2030
Series Year2026-2030
Growth MomentumAccelerate
YOY 20265.6%
CAGR6.1%
Incremental Value$898.9 mn

Technavio's neurodiagnostic and monitoring devices market in US is segmented as below:

By Application

  • Stroke
  • Migraine
  • Epilepsy
  • Parkinsons disease
  • Ischemic stroke

By Product

  • ICP monitoring devices
  • EEG devices
  • EMG devices
  • Others

By End-User

  • Hospitals
  • Clinics
  • Laboratories

By Technology

  • Non-invasive monitoring
  • Invasive monitoring

Geography

  • North America
    • US

This study identifies the decentralization toward ambulatory and long-term in-home neurological telemetry as one of the prime reasons driving the neurodiagnostic and monitoring devices market in US growth during the next few years. Also, transition toward dry sensor interfaces and gel-free electrode configurations and convergence of noninvasive cerebral oximetry and advanced multimodal hemodynamic monitoring will lead to sizable demand in the market.

The report on the neurodiagnostic and monitoring devices market in US covers the following areas:

  • Neurodiagnostic and monitoring devices market in US sizing
  • Neurodiagnostic and monitoring devices market in US forecast
  • Neurodiagnostic and monitoring devices market in US industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurodiagnostic and monitoring devices market in US vendors that include Advanced Brain Monitoring Inc., Blackrock Microsystems Inc., Brain Products GmbH, BrainScope Co. Inc., Cadwell Industries Inc., Ceribell Inc., Compumedics Ltd., DEYMED Diagnostic sro, Digitimer Ltd., EB Neuro Spa, GE HealthCare Technologies, inomed Medizintechnik GmbH, Integra LifeSciences Corp., Koninklijke Philips NV, Masimo Corp., Medtronic Plc, Natus Medical Inc., Neuroelectrics Barcelona SLU, NeuroMetrix Inc., Nihon Kohden Corp., SOMNOmedics GmbH. Also, the neurodiagnostic and monitoring devices market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR40602

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Country Market Characteristics
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Technology
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2025
  • 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

  • 5.1 Neurodiagnostic And Monitoring Devices Market in US 2020 - 2024
    • Historic Market Size - Data Table on Neurodiagnostic And Monitoring Devices Market in US 2020 - 2024 ($ million)
  • 5.2 Application segment analysis 2020 - 2024
    • Historic Market Size - Application Segment 2020 - 2024 ($ million)
  • 5.3 Product segment analysis 2020 - 2024
    • Historic Market Size - Product Segment 2020 - 2024 ($ million)
  • 5.4 End-user segment analysis 2020 - 2024
    • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
  • 5.5 Technology segment analysis 2020 - 2024
    • Historic Market Size - Technology Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on neurodiagnostic and monitoring devices market in US
  • 6.2 Impact of geopolitical conflicts on neurodiagnostic and monitoring devices market in US

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2025 and 2030
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2025 and 2030
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2025 and 2030
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2025 and 2030
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2025 and 2030
  • 7.7 Market condition

8 Market Segmentation by Application

  • 8.1 Market segments
  • 8.2 Comparison by Application
  • 8.3 Stroke - Market size and forecast 2025-2030
  • 8.4 Migraine - Market size and forecast 2025-2030
  • 8.5 Epilepsy - Market size and forecast 2025-2030
  • 8.6 Parkinsons disease - Market size and forecast 2025-2030
  • 8.7 Ischemic stroke - Market size and forecast 2025-2030
  • 8.8 Market opportunity by Application
    • Market opportunity by Application ($ million)

9 Market Segmentation by Product

  • 9.1 Market segments
  • 9.2 Comparison by Product
  • 9.3 ICP monitoring devices - Market size and forecast 2025-2030
  • 9.4 EEG devices - Market size and forecast 2025-2030
  • 9.5 EMG devices - Market size and forecast 2025-2030
  • 9.6 Others - Market size and forecast 2025-2030
  • 9.7 Market opportunity by Product
    • Market opportunity by Product ($ million)

10 Market Segmentation by End-user

  • 10.1 Market segments
  • 10.2 Comparison by End-user
  • 10.3 Hospitals - Market size and forecast 2025-2030
  • 10.4 Clinics - Market size and forecast 2025-2030
  • 10.5 Laboratories - Market size and forecast 2025-2030
  • 10.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)

11 Market Segmentation by Technology

  • 11.1 Market segments
  • 11.2 Comparison by Technology
  • 11.3 Non-invasive monitoring - Market size and forecast 2025-2030
  • 11.4 Invasive monitoring - Market size and forecast 2025-2030
  • 11.5 Market opportunity by Technology
    • Market opportunity by Technology ($ million)

12 Customer Landscape

  • 12.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Drivers, Challenges, and Opportunity

  • 13.1 Market drivers
    • Escalating incidence of acute neurological conditions and rapid bedside adoption
    • Integration of AI and automated clinical workflow solutions
    • Surging adoption of continuous intraoperative monitoring in complex surgeries
  • 13.2 Market challenges
    • Reimbursement ambiguity and complex payer coverage frameworks
    • Cybersecurity vulnerabilities and network security integration challenges
    • High capital expenditure requirements and institutional budgetary constraints
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030
  • 13.4 Market opportunities
    • Decentralization toward ambulatory and long-term in-home neurological telemetry
    • Transition toward dry sensor interfaces and gel-free electrode configurations
    • Convergence of noninvasive cerebral oximetry and advanced multimodal hemodynamic monitoring

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Advanced Brain Monitoring Inc.
    • Advanced Brain Monitoring Inc. - Overview
    • Advanced Brain Monitoring Inc. - Product / Service
    • Advanced Brain Monitoring Inc. - Key offerings
    • SWOT
  • 15.5 Blackrock Microsystems Inc.
    • Blackrock Microsystems Inc. - Overview
    • Blackrock Microsystems Inc. - Product / Service
    • Blackrock Microsystems Inc. - Key offerings
    • SWOT
  • 15.6 Brain Products GmbH
    • Brain Products GmbH - Overview
    • Brain Products GmbH - Product / Service
    • Brain Products GmbH - Key offerings
    • SWOT
  • 15.7 Cadwell Industries Inc.
    • Cadwell Industries Inc. - Overview
    • Cadwell Industries Inc. - Product / Service
    • Cadwell Industries Inc. - Key offerings
    • SWOT
  • 15.8 Ceribell Inc.
    • Ceribell Inc. - Overview
    • Ceribell Inc. - Business segments
    • Ceribell Inc. - Key offerings
    • Ceribell Inc. - Segment focus
    • SWOT
  • 15.9 Compumedics Ltd.
    • Compumedics Ltd. - Overview
    • Compumedics Ltd. - Business segments
    • Compumedics Ltd. - Key offerings
    • Compumedics Ltd. - Segment focus
    • SWOT
  • 15.10 EB Neuro Spa
    • EB Neuro Spa - Overview
    • EB Neuro Spa - Product / Service
    • EB Neuro Spa - Key offerings
    • SWOT
  • 15.11 GE HealthCare Technologies
    • GE HealthCare Technologies - Overview
    • GE HealthCare Technologies - Business segments
    • GE HealthCare Technologies - Key news
    • GE HealthCare Technologies - Key offerings
    • GE HealthCare Technologies - Segment focus
    • SWOT
  • 15.12 inomed Medizintechnik GmbH
    • inomed Medizintechnik GmbH - Overview
    • inomed Medizintechnik GmbH - Product / Service
    • inomed Medizintechnik GmbH - Key offerings
    • SWOT
  • 15.13 Integra LifeSciences Corp.
    • Integra LifeSciences Corp. - Overview
    • Integra LifeSciences Corp. - Business segments
    • Integra LifeSciences Corp. - Key offerings
    • Integra LifeSciences Corp. - Segment focus
    • SWOT
  • 15.14 Koninklijke Philips NV
    • Koninklijke Philips NV - Overview
    • Koninklijke Philips NV - Business segments
    • Koninklijke Philips NV - Key news
    • Koninklijke Philips NV - Key offerings
    • Koninklijke Philips NV - Segment focus
    • SWOT
  • 15.15 Masimo Corp.
    • Masimo Corp. - Overview
    • Masimo Corp. - Product / Service
    • Masimo Corp. - Key offerings
    • SWOT
  • 15.16 Medtronic Plc
    • Medtronic Plc - Overview
    • Medtronic Plc - Business segments
    • Medtronic Plc - Key news
    • Medtronic Plc - Key offerings
    • Medtronic Plc - Segment focus
    • SWOT
  • 15.17 Natus Medical Inc.
    • Natus Medical Inc. - Overview
    • Natus Medical Inc. - Product / Service
    • Natus Medical Inc. - Key offerings
    • SWOT
  • 15.18 Nihon Kohden Corp.
    • Nihon Kohden Corp. - Overview
    • Nihon Kohden Corp. - Business segments
    • Nihon Kohden Corp. - Key offerings
    • Nihon Kohden Corp. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!